Lotus Pharmaceutical

Founded in 1966 in Taiwan, Lotus Pharmaceutical is a top 20 global specialty pharmaceutical company. It develops, manufactures, and commercializes generics, branded medicines, 505(b)(2) products, biosimilars, and NCEs. The company focuses on oncology, immunology, CNS, primary care, women's health, and nephrology. With over 250 commercial products in 90+ markets, Lotus operates manufacturing sites certified by US FDA, EU EMA, Japan PMDA, and others. Its hybrid R&D and licensing strategy drives a pipeline of 80+ projects.